The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Azuzote 30 mg film-coated tablets

30 milligram(s) Film-coated tablet

Azure Pharmaceuticals LtdPA22871/001/001

Main Information

Trade NameAzuzote 30 mg film-coated tablets
Active SubstancesNEFOPAM HYDROCHLORIDE
Strength30 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderAzure Pharmaceuticals Ltd
Licence NumberPA22871/001/001

Group Information

ATC CodeN02BG06 nefopam

Status

Authorised/WithdrawnAuthorised
Licence Issued24/01/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back